PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cardiology Department, Medical Faculty, Urmia University of Medical Sciences, Urmia, Iran.\', \'Medical Immunology, Laboratory Sciences, School of Allied Medical Sciences, Urmia University of Medical Sciences, Urmia, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2147/DDDT.S262491
?:doi
?:hasPublicationType
?:journal
  • Drug design, development and therapy
is ?:pmid of
?:pmid
?:pmid
  • 32753842
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.974
?:rankingScore_hIndex
  • 40
is ?:relation_isRelatedTo_publication of
?:title
  • Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32753842>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32753842>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all